Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases
- 31 March 2005
- journal article
- research article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 31 (2), 141-146
- https://doi.org/10.1016/j.ejso.2004.07.030
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- 1088 Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI group study 40986European Journal of Cancer Supplements, 2003
- Neoadjuvant Treatment with Weekly High-Dose 5-Fluorouracil as 24-Hour Infusion, Folinic Acid and Oxaliplatin in Patients with Primary Resectable Liver Metastases of Colorectal CancerOncology, 2003
- Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouraeil and folinic acidAnnals Of Oncology, 2001
- Lebermetastasen – primäre oder multimodale Therapie?Der Chirurg, 2001
- Resektion colorectaler Lebermetastasen Welche Prognosefaktoren bestimmen die Patientenselektion?Der Chirurg, 2001
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995
- Factors influencing the natural history of colorectal liver metastasesThe Lancet, 1994
- Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of SurgeryPublished by Springer Science and Business Media LLC ,1992